Related Experiment Video
Updated: Sep 18, 2025
08:58
Optogenetic Manipulation of Neural Circuits During Monitoring Sleep/wakefulness States in Mice
Published on: June 19, 2019
9.9K
Insomnia Neurobiology and Therapy
Alexa Kane1, Rachel Marie E Salas2
1Division of Allergy, Pulmonary and Sleep Medicine, Department of Psychiatry and Psychology, Mayo Clinic, Jacksonville, Florida.
Seminars in Neurology
|June 26, 2025
Summary
Insomnia is common and impacts health. This review covers insomnia mechanisms, including hyperarousal and neurobiology, and discusses treatments like CBT-I and medications.
Area of Science:
- Sleep Medicine
- Neuroscience
- Psychiatry
Background:
- Insomnia is a prevalent condition affecting clinical practice.
- It can occur independently or co-occur with other health issues.
- Insomnia exacerbates existing medical and mental health conditions.
Purpose of the Study:
- To review key mechanisms underlying insomnia.
- To explore the neurobiology and hyperarousal models of insomnia.
- To summarize current and emerging treatment strategies.
Main Methods:
- Review of existing literature on insomnia mechanisms.
- Analysis of neurobiological and hyperarousal theories.
- Synthesis of data on various treatment modalities.
Main Results:
- Insomnia is linked to specific neurobiological pathways.
- The hyperarousal model provides a framework for understanding insomnia.
- Multiple treatment options exist, including behavioral and pharmacological approaches.
Conclusions:
- Understanding insomnia's mechanisms is crucial for effective management.
- Cognitive Behavioral Therapy for Insomnia (CBT-I) is a primary treatment.
- Pharmacological and adjunctive therapies offer additional management options.
More Related Videos
05:59Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
2.6K
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
5.5K
Related Concept Videos
01:19Management of Insomnia
328
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
328
01:27Insomnia
132
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
132
01:24Sleep-Wake Cycles
1.6K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.6K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
247
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
247
01:14CNS Depressants: Barbiturates and Benzodiazepines
480
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
480
01:07Narcolepsy
204
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
204